Kwality Pharmaceuticals Limited informed the exchange that it had completed the EU GMP Inspection for its Cephalosporin and Oncology manufacturing unit in Himachal Pradesh. The GMP inspection of the site was conducted between April 18, 2023 to April 22, 2023.
At the end of inspection, it is concluded that the Quality system followed at the Himachal site is compliant with the EU GMP Standards.
The EU- GMP approval is an important stepping stone in the journey of the company and will help to expand and strengthen its presence in more regulated markets and will enable them access global markets. It allows the company to market its products in all the twenty-seven member countries of the EU.
This approval reaffirms the company’s focused efforts to maintain the GMP status up to the standards of global regulatory authorities.